Evidence map›Paper›PMID 41343234›Full record

ArticleJournal of chemical theory and computation2025

Sampling High-Dimensional Conformational Free Energy Landscapes of Active Pharmaceutical Ingredients.

Alexandre Ferreira, Rui Guo, Ivan Marziano, Matteo Salvalaglio

Abstract read
In one paragraph

Article in Journal of chemical theory and computation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alexandre FerreiraThomas Young Centre and Department of Chemical Engineering, University College London, London Wc1e 7je, United Kingdom.
Rui GuoPfizer Worldwide Research & Development, Sandwich Ct13 9nd, United Kingdom.
Ivan MarzianoPfizer Worldwide Research & Development, Sandwich Ct13 9nd, United Kingdom.ORCID 0000-0002-3759-0070
Matteo SalvalaglioThomas Young Centre and Department of Chemical Engineering, University College London, London Wc1e 7je, United Kingdom.ORCID 0000-0003-3371-2090

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a gridless framework for computing high-dimensional conformational free energy surfaces (FES) of flexible molecules using enhanced sampling trajectories. By combining concurrent well-tempered metadynamics with Density Peaks Advanced (DPA) clustering, our approach bypasses the dimensionality limitations of conventional grid-based FES reconstruction. Free energies are assigned on a per-configuration basis via local density estimation and Zwanzig reweighting, allowing for a direct, resolution-independent mapping of the conformational ensemble. Conformers are identified as density peaks in torsional angle space, and convergence is assessed via systematic consistency metrics. We validate this approach by reproducing the paradigmatic FES of alanine dipeptide and extend it to explore molecules with 4-, 7-, and 11-dimensional torsional angle spaces. As a key application, we investigate the solvent-dependent conformational preferences of bicalutamide in vacuum, chloroform, and DMSO. The predicted global minima reflect the known solvent-induced conformational shift between open and closed forms, in agreement with NMR and crystallographic data. These results demonstrate that our workflow provides a scalable route to high-dimensional conformational free energy landscapes, with direct relevance for polymorphism, solvation, and drug design.

Indexed as

Tosyl CompoundsBulk DrugsDipeptidesMolecular ConformationMolecular Dynamics SimulationNitrilesPharmaceutical PreparationsThermodynamicsBulk DrugsDipeptidesNitrilesPharmaceutical PreparationsTosyl Compounds

Identifiers

PMID41343234
PMCPMC12746462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.